LSU may be about to sell its stake in TransGenRx, a biopharmaceutical manufacturing company founded in 2003 that essentially uses genetically altered eggs to produce proteins for human medicines. The …
LSU may be about to sell its stake in TransGenRx, a biopharmaceutical manufacturing company founded in 2003 that essentially uses genetically altered eggs to produce proteins for human medicines. The …